Literature DB >> 19788422

A superoxide dismutase-human hemoglobin fusion protein showing enhanced antioxidative properties.

Marie Grey1, Sakda Yainoy, Virapong Prachayasittikul, Leif Bülow.   

Abstract

Much of the toxicity of Hb has been linked to its redox activity; Hb may generate reactive oxygen species, such as the superoxide anion. Superoxide is intrinsically toxic, and superoxide dismutase (SOD) provides important cellular protection. However, if the Hb molecule is located outside the red blood cell, the normal protection systems involving SOD and catalase are no longer closely associated with it, exposing Hb and its cellular surroundings to oxidative damage. In order to produce less toxic Hb molecules, we have explored gene fusion to obtain homogeneous SOD-Hb conjugates. The chimeric protein was generated by coexpressing the human Hb alpha-chain/manganese SOD gene together with the beta-chain gene in Escherichia coli. We show that the engineered SOD-Hb fusion protein retains the oxygen-binding capacity and, moreover, decreases cytotoxic ferrylHb (HbFe(4+)) formation when challenged with superoxide radicals. The SOD-Hb fusion protein also exhibits a 44% lower autoxidation rate and higher thermal stability than Hb alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788422     DOI: 10.1111/j.1742-4658.2009.07323.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  4 in total

1.  Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb-SOD-CAT) for protection from free radical stress.

Authors:  Venkatareddy Nadithe; You Han Bae
Journal:  Int J Biol Macromol       Date:  2010-08-17       Impact factor: 6.953

Review 2.  Targeting antioxidant and antithrombotic biotherapeutics to endothelium.

Authors:  Ronald Carnemolla; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Semin Thromb Hemost       Date:  2010-05-20       Impact factor: 4.180

3.  Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

Authors:  Devika S Manickam; Anna M Brynskikh; Jennifer L Kopanic; Paul L Sorgen; Natalia L Klyachko; Elena V Batrakova; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2012-08-10       Impact factor: 9.776

4.  Enhancement of Solubility and Specific Activity of a Cu/Zn Superoxide Dismutase by Co-expression with a Copper Chaperone in Escherichia coli.

Authors:  Warawan Eiamphungporn; Sakda Yainoy; Virapong Prachayasittikul
Journal:  Iran J Biotechnol       Date:  2016-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.